Broadly speaking we are in a mess over breast carcinoma. It has always been so and anyone industrious enough to study the literature in depth will have realised it. Despite the past twenty years of frenetic investigation, therapeutic revolution and comprehensive trials, the end results are not improved. (Forrest report 1986 Sadly, under the age of 50, there is uniform agreement that screening is of no benefit in mortality. Over that age it may bear fruit. Theoretically it should be beneficial if more 'T0, N0' tumours are discovered and this hope has clearly buoyed up so many. Hence the political bandwagon is rolling; the disturbance and organisational ferment will be considerable; the anguish of cost effectiveness will be ever present; we still have to manufacture the surgical sessions and much time will have to be side-tracked into audit, recapitulation, rethink and whatever. In the end we may save 40 deaths in 78,000 women over a ten year period. 
